Is Korea Prepared for an Alzheimer’s Disease-Modifying Therapy? Assessing the Korean Healthcare System Infrastructure and the Effect of Blood-Based Biomarker Tests

by Hankyung Jun, Sang Kyu Cho, Joanne Yoong, Soeren Mattke
Published 2021-03-01

Blood‐based biomarkers for Alzheimer's pathology and the diagnostic process for a disease‐modifying treatment: Projecting the impact on the cost and wait times

by Soeren Mattke, Sang Kyu Cho, Tobias Bittner, Jakub Hlávka, Mark Hanson
Published 2020-01-01